KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cigna (CI) Common Equity (2017 - 2025)

Cigna (CI) has disclosed Common Equity for 9 consecutive years, with $41.9 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 1.53% to $41.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.9 billion through Dec 2025, up 1.53% year-over-year, with the annual reading at $41.9 billion for FY2025, 1.53% up from the prior year.
  • Common Equity hit $41.9 billion in Q4 2025 for Cigna, roughly flat from $42.0 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $48.7 billion in Q2 2021 to a low of $40.4 billion in Q1 2025.
  • Historically, Common Equity has averaged $44.3 billion across 5 years, with a median of $44.7 billion in 2022.
  • Biggest five-year swings in Common Equity: grew 6.81% in 2021 and later decreased 10.81% in 2024.
  • Year by year, Common Equity stood at $47.0 billion in 2021, then decreased by 4.87% to $44.7 billion in 2022, then rose by 3.48% to $46.2 billion in 2023, then dropped by 10.81% to $41.2 billion in 2024, then grew by 1.53% to $41.9 billion in 2025.
  • Business Quant data shows Common Equity for CI at $41.9 billion in Q4 2025, $42.0 billion in Q3 2025, and $40.4 billion in Q2 2025.